Form D · Other Health Care
FreMon Scientific, Inc.
La Jolla, CA · CIK 0001735152
Offering snapshot reported Apr 11, 2019 · SEC filing
- Reported sold
- $2.11M Offering amount: $4M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 11, 2019 | Initial | $2,105,362 | No comparison | 30 | SEC filing |
| Mar 21, 2018 | Initial | $2,012,371 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-337139
Source: Form D, filed Apr 11, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Farideh Bischoff | Executive |
| Joseph Cohen | Director |
| Thomas Rosenbloom | Director |
| Menachem Shavit | Director |
| Frederick Thacher | Director, Executive |
| Fred Thacher | Director, Executive |
| Salvatore Viscomi | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5726 La Jolla Blvd, Suite 304
La Jolla, CA, 92037
La Jolla, CA, 92037